深圳光大同创新材料股份有限公司监事会 关于2024年限制性股票激励计划第一个解除限售期及首次授予第一 个归属期激励对象名单的核查意见 根据《中华人民共和国公司法》（以下简称《公司法》）、《中华人民共和国证 券法》（以下简称《证券法》）、《上市公司股权激励管理办法》（以下简称《管理 办法》）、《深圳证券交易所创业板股票上市规则》（以下简称《上市规则》）、《深 圳证券交易所创业板上市公司自律监管指南第 1 号——业务办理》《深圳光大同 创新材料股份有限公司章程》（以下简称《公司章程》）等有关规定，深圳光大同 创新材料股份有限公司（以下简称"公司"）全体监事认真审阅相关会议资料， 经充分、全面的讨论与分析，就《2024 年限制性股票激励计划（草案）》（以下 简称《激励计划》或"本激励计划"）第一个解除限售期及首次授予第一个归属 期激励对象名单进行了核查，发表核查意见如下： （一）关于 2024 年限制性股票激励计划第一个解除限售期激励对象名单的 核查意见 本次可解除限售的 2 名激励对象符合《公司法》《证券法》《公司章程》等规 定的任职资格，符合《上市规则》及公司《激励计划》规定的激励对象条件，符 合本激励计划规定 ...

证券代码：301387 证券简称：光大同创 公告编号：2025-032 深圳光大同创新材料股份有限公司 关于 2024 年限制性股票激励计划第一个解除限售期 2、股票来源：公司向激励对象定向发行公司 A 股普通股股票。 3、权益数量：本激励计划拟授予的第一类限制性股票及第二类限制性股票 数量合计不超过 152.00 万股，约占本激励计划草案公告时公司股本总额的 2.00%。 其中，首次授予 126.75 万股，约占本激励计划公告时公司股本总额的 1.67%，约 占本激励计划权益授予总额的 83.39%；预留授予 25.25 万股，约占本激励计划公 告时公司股本总额的 0.33%，约占本激励计划权益授予总额的 16.61%。 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 重要内容提示： 1、符合资格的2名激励对象可申请解除限售的第一类限制性股票共计1.9656 万股，约占公司当前总股本的0.02%； 2、本次限制性股票解除限售事宜尚需经有关机构办理手续结束后方可解除 限售，届时公司将另行公告，敬请投资者注意。 深圳光大同创新材料股份有限公司（以下简称"公司"） ...

证券代码：301387 证券简称：光大同创 公告编号：2025-033 深圳光大同创新材料股份有限公司 关于 2024 年限制性股票激励计划首次授予第一个归属期归属条件成 就的公告 2、归属股票来源：公司向激励对象定向发行公司 A 股普通股股票。 深圳光大同创新材料股份有限公司（以下简称"公司"）2024 年限制性股 票激励计划（草案）》（以下简称"本激励计划"或《激励计划》）第二类限制 性股票首次授予第一个归属期归属条件已经成就。根据公司 2024 年第一次临时 股东大会的授权，公司于 2025 年 4 月 28 日召开第二届董事会第十次会议和第二 届监事会第十次会议，审议通过了《关于 2024 年限制性股票激励计划首次授予 第一个归属期归属条件成就的议案》。现将有关事项说明如下： 一、本激励计划简述及已履行的审批程序 （一）本激励计划简述 1、激励方式：本激励计划包括第一类限制性股票激励计划和第二类限制性 股票激励计划两个部分。 2、股票来源：公司向激励对象定向发行公司 A 股普通股股票。 3、权益数量：本激励计划拟授予的第一类限制性股票及第二类限制性股票 数量合计不超过 152.00 万股，约占本激励计 ...

深圳市他山企业管理咨询有限公司 第一个解除限售期解除限售条件及首次授予第一个 归属期归属条件成就、回购注销部分限制性股票及 部分限制性股票作废事项的 独立财务顾问报告 关于深圳光大同创新材料股份有限公司 2024 年限制性股票激励计划 二〇二五年四月 | 释 义 2 | | --- | | 声 明 4 | | 一、本激励计划已履行的必要程序 5 | | 二、本次回购注销限制性股票的具体情况 7 | | 三、本次作废限制性股票的具体情况 10 | | 四、本激励计划第一个解除限售期解除限售条件成就的情况 12 | | 五、本激励计划首次授予第一个归属期归属条件成就的情况 15 | | 六、独立财务顾问意见 18 | | 七、备查文件及备查地点 19 | 深圳市他山企业管理咨询有限公司 独立财务顾问报告 释 义 在本报告中，除非上下文文意另有所指，下列词语具有如下含义： | 光大同创、公司 | 指 | 深圳光大同创新材料股份有限公司 | | --- | --- | --- | | 本计划、本激励计划 | 指 | 深圳光大同创新材料股份有限公司 2024 年限制性股 | | | | 票激励计划 | | 第一类限制性 ...

北京 西安 深圳 海口 上海 广州 杭州 沈阳 南京 天津 菏泽 成都 苏州 呼和浩特 香港 武汉 郑州 长沙 厦门 重庆 合肥 宁波 济南 昆明 南昌 关于深圳光大同创新材料股份有限公司 2024 年限制性股票激励计划第一个解除限售期解除限售条件成 就、首次授予第一个归属期归属条件成就、回购注销部分限制 性股票及作废部分限制性股票相关事项的 法律意见书 康达法意字【2025】第 0201 号 北京市朝阳区建外大街丁 12 号英皇集团中心 8、9、11 层 8/9/11/F, Emperor Group Centre, No.12D, Jianwai Avenue, Chaoyang District, Beijing, 100022, P.R.China 电话/Tel.:010-50867666 传真/Fax:010-56916450 网址/Website:www.kangdalawyers.com 致：深圳光大同创新材料股份有限公司 北京市康达律师事务所（以下简称"本所"）受深圳光大同创新材料股份有 限公司（以下简称"光大同创"或"公司"）委托，作为公司本次限制性股票激 励计划（以下简称"本激励计划"或" ...

Financial Performance - The company's revenue for Q1 2025 was CNY 347,329,633.58, representing a 51.16% increase compared to CNY 229,777,520.78 in the same period last year[5]. - Net profit attributable to shareholders was CNY 17,761,824.56, up 55.88% from CNY 11,394,326.11 year-on-year[5]. - The company reported a basic earnings per share of CNY 0.1669, a 55.84% increase from CNY 0.1071 in the same period last year[5]. - Net profit for the current period was CNY 17,829,750.83, compared to CNY 10,934,034.14 in the previous period, showing a growth of approximately 63.5%[19]. - The total comprehensive income amounted to CNY 18,457,024.17, compared to CNY 11,658,167.65 in the previous period, indicating an increase of about 58.5%[20]. - Basic earnings per share were CNY 0.1669, up from CNY 0.1071, reflecting a growth of approximately 56%[20]. Cash Flow - The net cash flow from operating activities decreased by 74.32% to CNY 8,602,635.14, down from CNY 33,498,742.03 in the previous year[5]. - Cash flow from operating activities generated a net cash flow of CNY 8,602,635.14, down from CNY 33,498,742.03 in the previous period, a decrease of about 74.3%[23]. - Cash flow from investing activities showed a net inflow of CNY 116,372,640.24, a significant improvement from a net outflow of CNY 21,533,092.18 in the previous period[23]. - The company’s financing activities generated a net cash inflow of CNY 14,502,236.62, compared to a net outflow of CNY 4,237,763.81 in the previous period, indicating a turnaround in financing activities[23]. Assets and Liabilities - Total assets increased by 2.69% to CNY 2,385,031,475.76 from CNY 2,322,571,296.79 at the end of the previous year[5]. - Current liabilities totaled CNY 647,508,795.98, compared to CNY 596,496,550.66, indicating a rise in short-term obligations[16]. - The company’s total liabilities increased to CNY 722,847,913.03 from CNY 680,986,917.74, reflecting a growth in overall debt[16]. - The company’s retained earnings grew to CNY 337,691,751.32 from CNY 319,929,926.76, indicating a positive trend in profit retention[16]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 10,291[10]. - The largest shareholder, Shenzhen Huike Zhixuan Investment Partnership, holds 28.12% of shares, amounting to 29,942,465 shares, with 11,130,000 shares pledged[10]. - Zhang Jingtao, a natural person, holds 21.12% of shares, totaling 22,485,743 shares[10]. - The total number of shares held by the top 10 unrestricted shareholders includes Shenzhen Yuxi Venture Capital with 11,060,554 shares[10]. - The total number of shares held by Li Baiquan is 526,100, all held through a credit trading guarantee account[11]. - The total number of shares held by You Tao is 241,620, with 130,600 shares held through a regular securities account[11]. - The company has not reported any changes in the top 10 shareholders due to securities lending or borrowing[11]. Operational Highlights - The company included Chongqing Zhiguan Technology Co., Ltd. in its consolidated financial statements, contributing to the revenue growth[8]. - Investment income improved significantly, with a profit of CNY 363,184.78 compared to a loss of CNY 94,537.88 in the previous year, marking a 484.17% change[8]. - The company reported a significant increase in cash flow from investing activities, amounting to CNY 116,372,640.24, compared to a negative cash flow of CNY 21,533,092.18 in the previous year[8]. - Total operating revenue for the current period reached CNY 347,329,633.58, compared to CNY 229,777,520.78 in the previous period, indicating a significant increase[18]. - Total operating costs amounted to CNY 328,156,565.37, up from CNY 222,297,881.44, reflecting a rise in operational expenses[19]. - The company received CNY 353,084,014.52 from sales of goods and services, compared to CNY 277,635,002.70 in the previous period, indicating an increase of about 27.2%[22]. - The company paid CNY 278,221,906.10 for goods and services, up from CNY 186,446,371.56, reflecting an increase of approximately 49.2%[23]. Stock Incentive Plan - The company has adjusted the grant price of the 2024 restricted stock incentive plan from 26.27 RMB/share to 18.41 RMB/share, increasing the initial grant quantity from 1,202,500 shares to 1,683,500 shares[11]. - The company plans to grant 353,500 shares of restricted stock to 13 eligible incentive objects on January 15, 2025[11]. Miscellaneous - The financial statements for the quarter ending March 31, 2025, are being prepared and will be disclosed[13]. - Accounts receivable slightly decreased to CNY 615,861,815.42 from CNY 618,488,675.67, showing a marginal decline[15]. - Inventory levels rose to CNY 214,219,598.40 from CNY 169,107,500.08, indicating an increase of about 26.7%[15]. - Cash and cash equivalents increased to CNY 402,057,800.05 from CNY 259,221,123.40, representing a growth of approximately 55%[15]. - The cash and cash equivalents at the end of the period totaled CNY 378,268,016.89, an increase from CNY 282,873,462.24 at the end of the previous period, representing a growth of approximately 33.7%[24]. - The company reported a decrease in cash received from tax refunds to CNY 15,518,866.87 from CNY 17,271,741.92 in the previous period, a decline of about 10.2%[23].

Core Insights - Everbright Tongchuang (301387.SZ) released its 2024 annual report on April 22, 2025, indicating that 27 institutional investors disclosed holdings totaling 54.1361 million shares, representing 50.84% of the company's total equity [1] - The top ten institutional investors collectively hold 50.79% of the shares, with a slight decrease of 0.29 percentage points compared to the previous quarter [1] Institutional Holdings - The top ten institutional investors include Shenzhen Huike Zhixuan Investment Partnership, Shenzhen Tongchuang Zhixuan Investment Partnership, and others [1] - In the public fund sector, 21 new public funds were disclosed this period, including Debon Fuxin A and others [1] Foreign Investment - One foreign fund, MORGAN STANLEY & CO. INTERNATIONAL PLC., increased its holdings by 0.20% compared to the previous period [2] - Goldman Sachs did not disclose any holdings this quarter [2]

Core Insights - The company reported a significant increase in revenue for 2024, achieving 1,222,665,345.61 yuan, a growth of 21.47% compared to 2023 [2] - However, net profit plummeted by 82.16%, falling to 20,460,270.22 yuan from 114,665,193.63 yuan in the previous year [3] - The decline in net profit is attributed to multiple factors, including increased production costs, market competition, and rising operational expenses [3][4] Revenue Growth - Revenue growth of 21.47% was driven by protective products and functional products, with the latter seeing a 36.84% increase [2] - Domestic revenue accounted for 88.01% of total revenue, growing by 26.59%, while international revenue decreased by 6.33% [2] Profitability Challenges - The company's net profit decline reflects a significant impact on core business profitability, with non-recurring profit dropping by 80.94% [4] - Basic earnings per share fell to 0.1922 yuan, a decrease of 83.65% from the previous year, indicating reduced shareholder returns [5] Expense Analysis - Total expenses increased, with management expenses rising by 44.23% due to higher salaries and digital transformation costs [6] - Research and development expenses grew by 47.83%, reflecting the company's commitment to innovation despite short-term profit erosion [6][7] Cash Flow Dynamics - Operating cash flow increased by 12.14% to 78,322,152.01 yuan, indicating improved cash generation from core operations [8] - Investment cash flow losses decreased significantly, suggesting better management of investment activities [8] Strategic Focus - The company is enhancing its R&D capabilities, with a 6.34% revenue allocation to R&D and an increase in R&D personnel [7] - Management compensation remains high despite the profit decline, raising questions about alignment with company performance [11]

Core Viewpoint - The article discusses the recent performance and trends in the investment banking sector, highlighting significant changes in market dynamics and company strategies [1]. Group 1: Market Performance - The investment banking industry has seen fluctuations in stock prices, with notable declines in certain sectors [1]. - There is an increasing trend in mergers and acquisitions, indicating a potential recovery in market confidence [1]. Group 2: Company Strategies - Companies are adapting their strategies to focus on digital transformation and enhancing client services [1]. - There is a shift towards sustainable investment practices, reflecting changing investor preferences [1]. Group 3: Financial Metrics - Recent financial reports indicate a mixed performance, with some firms reporting increased revenues while others face challenges [1]. - The overall market capitalization of key players in the sector has experienced volatility, impacting investor sentiment [1].

东方证券股份有限公司 关于深圳光大同创新材料股份有限公司 持续督导现场培训报告 深圳证券交易所： 东方证券股份有限公司（以下简称"东方证券"或"保荐人"）作为深圳光 大同创新材料股份有限公司（以下简称"光大同创"或"公司"）首次公开发行 股票的保荐人，根据《深圳证券交易所上市公司自律监管指引第 13 号——保荐 业务》、《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规 范运作》的要求，对光大同创的实际控制人、董事、监事、高级管理人员进行了 培训，现将培训情况报告如下： 一、本次培训的基本情况 2025 年 4 月 18 日，保荐人持续督导人员对公司实际控制人、董事、监事、 高级管理人员进行了培训。 二、参加本次培训的人员 公司实际控制人以及公司董事、监事、高级管理人员。 三、本次培训的内容 本次培训的内容主要包括：《上市公司章程指引》等证券期货法规修订情况； 上市公司违法典型案例。 四、本次培训的成果 保荐人根据《深圳证券交易所上市公司自律监管指引第13号——保荐业务》、 《深圳证券交易所上市公司自律监管指引第2号——创业板上市公司规范运作》 等规定对光大同创的实际控制人、董事、监事和高级管 ...